FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2011/08/001941 [Registered on: 05/08/2011] Trial Registered Retrospectively
Last Modified On: 14/12/2011
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome 
Scientific Title of Study   A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Multicenter Study to Evaluate the Efficacy and Safety of Rivaroxaban in Subjects With a Recent Acute Coronary Syndrome 
Trial Acronym  ATLAS-ACS 2 
Secondary IDs if Any  
Secondary ID  Identifier 
BAY-59-7939/13194  Protocol Number 
NCT00809965  ClinicalTrials.gov 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name   
Designation   
Affiliation   
Address 




 
Phone    
Fax    
Email    
 
Details of Contact Person
Scientific Query
 
Name  Dr. Manish Garg 
Designation   
Affiliation  Country Medical Director India 
Address  Bayer Pharmaceuticals Private Limited
Kolshet Road
Thane
MAHARASHTRA
400607
India 
Phone  022-25311448  
Fax  022-25455080  
Email  manish.garg@bayer.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Manish Garg 
Designation   
Affiliation   
Address  Bayer Pharmaceuticals Private Limited
Kolshet Road
Thane
MAHARASHTRA
400607
India 
Phone  022-25311448  
Fax  022-25455080  
Email  manish.garg@bayer.com  
 
Source of Monetary or Material Support  
Bayer Pharmaceuticals Private Limited 
 
Primary Sponsor
Modification(s)  
Name  Johnson Johnson Pharmaceutical Research Development LLC  
Address  Johnson & Johnson, Global Clinical Operations, Johnson & Johnson Ltd, 9th Flr, Sigma, Hiranandani Estate, Powai, Mumbai, 400076 
Type of Sponsor  Pharmaceutical industry-Global 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     Argentina
Australia
Belgium
Brazil
Bulgaria
Canada
Chile
China
Colombia
Croatia
Czech Republic
Denmark
Egypt
France
Germany
Greece
Hungary
India
Israel
Italy
Japan
Latvia
Lithuania
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Philippines
Poland
Portugal
Republic of Korea
Romania
Russian Federation
Serbia
Slovakia
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
United States of America  
Sites of Study  
No of Sites = 54  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr. Purushotham  A J Hospital & Research Centre   A J Hospital & Research Centre (Dept. of Cardiology, AJIMS, Mangalore),ept. of Emergency & Trauma, AJHRC-575004

 
08242225533
8242430700
drrpurushotham@yahoo.com 
Dr. Manotosh Panja  AMRI Hospital  AMRI Hospital, Director of Cardiovascular Science , Department of Cardiology,AMRI Hospital, P 4 & 5, CITE Scheme, LXXII, Block A Gariahat Road, Beside Dhakuria Bridge-700029
Kolkata
WEST BENGAL 
09830318106
033-2461-2536
mpanja@vsnl.net 
Dr. Suvro Banerjee  Apollo Gleneagles Hospital   Apollo Gleneagles Hospital, 58,Canal Circular Road-700054
Kolkata
WEST BENGAL 
9830024131
033-23201739
baners@vsnl.net 
 Dr Abraham Oomman  Apollo Hospital  Apollo Hospital, No. 645/646,T.H. Road, Tondiarpet -600 081
Chennai
TAMIL NADU 
+91-9841174578
044 - 25911111
aherftondiarpet@gmail.com 
Dr Sudhir Naik  Apollo Hospitals  Heart Institute - Cardiology,Jubilee Hills,-500 033
Hyderabad
ANDHRA PRADESH 
040-23556622
91-40-23543270
drsudhirnaik04@yahoo.co.in 
Dr Hasit Joshi  Apollo Hospitals International Ltd.  Apollo Hospitals, 1A,Bhat GIDC Estate-382 428
Ahmadabad
GUJARAT 
91-11-25861766
91-011-42437230
aherf@apolloahd.com 
Dr. Darshan Banker  Bankers Heart Institute  Bankers Heart Institute,Old Padra Road-390015
Vadodara
GUJARAT 
02652324004
0265-2327401
info@bankersheart.com 
Dr. Parvindar Singh  Baroda Heart Institute & Research Centre  Baroda Heart Institute & Research Centre, 44,Haribhakti Colony, Old Padra Road-390007
Vadodara
GUJARAT 
91-265-2322021
912652351091
parvindar@yahoo.com 
Dr. Vikas Bisne  Bisne Heart Clinic & Hospital  Bisne Heart Hospital, 107/1,Farmland Ramdaspeth-440010
Nagpur
MAHARASHTRA 
0712-2436536
0712-2430313
vikas_bisne@hotmail.com 
Dr.Keyur Parikh  CIMS Hospital  CIMS Hospital, Near Shukan Mall,Off Science City Road-380060
Ahmadabad
GUJARAT 
+91-79-2771 2771-75
91-11-26225733
keyur.parikh@heartcareclinic.org 
Dr. Aziz Khan  Crescent Hospital and Heart Centre  Plot no 25, First Lane,Near Lokmat Square, Dhantoli-440012
Nagpur
MAHARASHTRA 
+91- 9823056551
91-712-2420698
khandraziz@yahoo.com 
Dr. Deepak Jeswani  Criticare Hospital  1st Floor, Vasant Sheela Tower,Opp Lokmat Building, Lokmat Square-440012
Nagpur
MAHARASHTRA 
0712-2440333
0712-2440444
deepakjeswani2@yahoo.co.in 
Dr. Shireesh Sathe  Deenanath Mangeshkar Hospital & Research Centre  Deenanath Mangeshkar Hospital & Research Centre,Erandawane-411 004
Pune
MAHARASHTRA 
(020)66023000
(020)25466584
shireesh.sathe@gmail.com 
Dr. Ramesh Babu Pothineni  Dr. Ramesh Cardiac & Multispeciality Hospital Ltd.  Dr. Ramesh Cardiac & Multispeciality Hospital Ltd. Department of Cardiology,Ring Road Near ITI College-520008

 
08666 2484800
2486094
Dr_rameshbabu.p@yahoo.co.in 
Dr.Nishith Chandra  Escorts Heart Institute & Research Center  Escorts Heart Institute & Research Center,Okhla Road-110025
New Delhi
DELHI 
91-11-25825000
91-11-26825112
drchandra@hotmail.com 
Dr. H.K Bali  Fortis Hospital  Fortis Hospital, Sector 62,Phase VIII-390007

 
0172-5096222
91-172-5096221
hkbalipgi@gmail.com 
Dr. Golla Nagendra Prasad  Frontier Lifeline  R-30-C,Ambattur Industrial Estate Road-600101
Chennai
TAMIL NADU 
91 44 42017575
+91-44-26565150
prasad_golla@yahoo.com 
Dr. Vimal Mehta  G.B Pant Hospital  Jawahar Lal Nehru Marg,Delhi Gate-110002
New Delhi
DELHI 
011-23234242
011-23234242
drvimalmehta@yahoo.co.in 
Dr. Navneet Kumar  Hinduja Hospital  Hinduja Hospital, Veer Savarkar Marg,Mahim-400016
Mumbai
MAHARASHTRA 
09820092961
2449151
dr.navneetkumar@rediffmail.com 
Dr. Sheoji Jaiswal  Jeevan Jyoti Hospital & Research Centre  Jeevan Jyoti Institute of Medical Sciences, 162,Bai Ka Bagh, Lowther Road-211003
Allahabad
UTTAR PRADESH 
91 9415633622
0532-2557119
dr.jaiswal.ct@gmail.com 
Dr. Jaskaran Singh Duggal  Jehangir Clinical Development Centre PVT. Ltd  Jehangir Hospital Premises,32, Sassoon Road-411001
Pune
MAHARASHTRA 
020-26059318
091 261 3072879
tonydugal@yahoo.co.in 
Dr. Subramanyam K.  K S. Hegde Charitable  Hospital  Medical Sciences Complex,Mangalore-575 018

 
91 9980837234
08242204016
drsubramanyam@rediffmail.com 
Dr. Bhavesh Thakker  Kalcadiya Hospital   Kalcadiya Hospital , B/H Sukhsagar Complex LB Shastri Marg,Opposite Dinesh Chamber Bapunagar-380025

 
079 22205858
(079)22203442
bthakkarin@yahoo.co.in 
Dr. Vijayaraghavan G  Kerala Institute of Medical Sciences  Kerala Institute of Medical Sciences, P.B.No.1,Anayara P.O-695029
Thiruvananthapuram
KERALA 
0471- 3041320
91-471-2446535
drvijayaraghavan@gmail.com 
Dr. Milind Gadkari  King Edward Memorial Hospital Research Centre  Dept of Cardiology, First floor, Echo Dept,DH Building, KEM Hospital, Rasta Peth-411011
Pune
MAHARASHTRA 
020-66037432
020-66202260
gadkaris@gmail.com 
Dr. Chockalingam Kulasekaran  Kovai Medical Centre & Hospital  P.Box #3209,Avanashi Road- 641014
Coimbatore
TAMIL NADU 
0422-4214020
0422-4214020
kclingam@gmail.com 
Dr. Sunil Thanvi  Krishna Heart Institute  Bhanubhai & Madhuben Patel Cardiac Centre,Shree Krishna Hospital & Medical Research Centre-388325

 
+91-9825012296
+91 2692 222493
sunilt@charutarhealth.org 
Dr. Rakesh Kumar Agarwal  Kulwant Heart & Vascular Centre  Kulwant Heart & Vascular Centre, 11-D,Kitchlu Nagar-141001
Ludhiana
PUNJAB 
91-1612304554
91-161-5047851
Aggarwal.rakeshkumar@yahoo.com 
Dr. K. A. Chacko  Lakeshore Hospital & Research Centre Ltd.  Lakeshore Hospital & Research Centre Ltd. NH-47,Byepass, Maradu, Nettoor-682304

 
91 484 2701032
91 484 2701966
kachacko@eth.net 
Dr. Sameer Dani  Lifecare Institute of Medical Science  Department of Cardiology, Sardar Patel Statue Corner,Sardar Patel Stadium Road, Naranpura, Naranpura Vistar-380013
Ahmadabad
GUJARAT 
079-40204020
079-26405210
danisameer@hotmail.com 
 Dr. Jabir Abdullakutty  Lisie Hospital  Lisie Hospital,P.B. #3053-682018

 
91-484-2403877
91-484-2403877
drjabi@yahoo.co.in 
 Dr. Sandeep Kumar Gupta  M. V Hospital & Research Centre  M. V Hospital & Research Centre, 314/30,Mirza Mandi Chowk-226003
Lucknow
UTTAR PRADESH 
91-522 2258215
0522 4016051
sandeepkumar.gupta@rediffmail.com 
Dr. Nagamalesh Madappa  M.S. Ramaiah Narayana Hrudatyalaya  Consultant Cardiologist, M.S. Ramaiah Narayana Hrudatyalaya,M.S. Ramaiah Memorial Hospital, MSRIT Post, New BEL Road-560054
Bangalore
KARNATAKA 
080-22183078
080-40528402
nmalesh@yahoo.co.in 
Dr. Nitin Patki   Maharashtra Medical Foundation Joshi Hospital  Maharashtra Medical Foundation Joshi Hospital,, 778,Opposite Kamala Nehru Park-411004
Pune
MAHARASHTRA 
09822041699
25651602
nitin1patki@gmail.com 
Dr. Jaydeep Menon  MAR Augustine Golden Jubilee Hospital  MAR Augustine Golden Jubilee Hospital,Mookkannoor (P.O)-683577

 
0484-2615700
0484-2616869
menon7jc@gmail.com 
Dr. Vijay Kumar Chopra  Medanta Heart Institute   Director Heart Failure Program Department of Cardiology,Medanta Heart Institute Medanta- The Medicity Sector-38-122001
Gurgaon
HARYANA 
9560398900
012448341111
vk.chopra@medanta.org 
Dr. Naveen Chander Reddy  Mediciti Hospitals  Medicti Hospitals, 5-9-22,Secretarait Road-64
Hyderabad
ANDHRA PRADESH 
040 23231111
040 23299078
prodduturnaveen@yahoo.co.in 
Dr. Sivakumar Rathnavel  Meenakshi Mission Hospital & Research Centre  Meenakshi Mission Hospital & Research Centre, Lake Area,Melur Road-625107
Madurai
TAMIL NADU 
0452 2588741
91-452-2586353
drsivakumar2004@yahoo.co.uk 
Dr. Vinod Sharma  National heart institute   National Heart Institute,Community Centre, -11 00 65
New Delhi
DELHI 
91-11-26428372
91-11-26225733
drvs1994@rediffmail.com 
Dr. Abhijit Joshi  Nirmaya Hospital  Nirmaya Hospital, Opp. Chinchwad Railway Station,Chinchwad -411019
Pune
MAHARASHTRA 
020 40717777
020-27441865
abhibhaskar100@rediffmail.com 
 Dr. Mukund Kumbla  Omega Hospital  Mahaveer Circle (Pump well),,Mangalore-575002

 
0824-2430000
0824-2432925
mukundkumble@hotmail.com 
Dr. P Sampath Kumar  Osmania General Hospital  Department of Cardiology,Near Afzalgunj Bus stop-500012
Hyderabad
ANDHRA PRADESH 
04023316989
4024736313
cardoGH@gmail.com 
Dr Krishnakumar K  PRS Hospital  PRS Hospital,Killipalam-695 002

 
0471234443
91-471-2345358
krishnasarith@rediffmail.com 
Dr. Bhuvaneswaran Jagadesa Subramaniam  PSG Hospitals  Department of Cardiology,Peelamedu-641 004
Coimbatore
TAMIL NADU 
0422-2570170
0422-4397910
drbhucbe@yahoo.co.in 
Dr. P. K. Grant  Ruby Hall Clinic  Ruby Hall Clinic, 40,Sassoon Road-40
Pune
MAHARASHTRA 
020-26123391
020-26051177
Purvez_grant@hotmail.com 
Dr.Kamal Sharma  Sanjivani Super Speciality Hospital  Sanjivani Super Speciality Hospital, 1, Uday Park Society,Near Sunrise park, Vastrapur-380051
Ahmadabad
GUJARAT 
9426020154
079-26307165
kamalsharma1975@rediffmail.com 
Dr. Atul Abyankar  Shree B.D Mehta Mahaveer Heart Institute  F -10 Sheron Plaza, Opp. Ambika Niketan Bus Stop,Next to Athwalines Road, Parle Point-395007
Surat
GUJARAT 
0261-2254888
0267-2462113
atulda@hotmail.com 
Dr. Jitendrapal Singh Sawhney  Sir Ganga Ram Hospital  Sir Ganga Ram Hospital, Department of cardiology,Dharam Vira Heart Center,5th floor , Old Rajinder Nagar-110060
New Delhi
DELHI 
91-11-25861766
91-011-42437230
jpssawhney@yahoo.com 
Dr. Nikhil Parikh  SK Soni Hospital  SK Soni Hospital, Cardiology Sector 5,Vidhyadhar Nagar-302013
Jaipur
RAJASTHAN 
01412232409
0141 2232412
nikhil1761@yahoo.co.in 
Dr. Prabhavathi   Sri Jayadeva Institute of Cardiology  Bannerughatta Road,Jayanagar 9th Block-560069
Bangalore
KARNATAKA 
080-22977222
080-26534477
prabhavathi_in@yahoo.com 
Dr. A.C Rao  SUT Hospital  Sut Hospital, Department of Cardiology, PB No 1052,Shree Uthradom Thirunal Hospital, Pattom-695004
Thiruvananthapuram
KERALA 
9387802792
0471-2444304
acr_rao@yahoo.co.in 
Dr. Vinod Vijan  Vijan Cardiac & Critical Care Centre  Vijan Cardiac & Critical Care Centre, Vijan House,Dr. Vijan Hospital Marg, College Road-422005
Nashik
MAHARASHTRA 
0253-2572371
0253-2577762
vmvijan@hotmail.com 
Dr. Arun Srinivas  Vikram Hospital and Heart Centre  Department of Cardiology,Vikram Hospital and Heart Care No. 46,Vivekananda Road, Yadavagiri-570020
Mysore
KARNATAKA 
91 9845028387
0821-4241813
arunsrinivas@vhpl.com 
Dr. P.P .Mohanan  Westfort Hi-Tech Hospital Ltd  Department of Cardiology,Poonkunnam-680002
Thrissur
KERALA 
9846076006
04872388854
drppmohanan@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 54  
Name of Committee  Approval Status 
AJ Ethical Committee  Approved 
Bankers Ethics Committee  Approved 
Baroda Heart Institute Ethics Committee  Approved 
Canara Research Ethical Committee  Approved 
Central Ethical Committee Nitte University  Approved 
Central Ethics Committee, Apollo Hospitals Group, Chennai  Approved 
Central Ethics Committee, Apollo Hospitals Group, Gujarat  Approved 
Central Ethics Committee, Apollo Hospitals Group, Hyderabad  Approved 
Central India Medical Research Ethics Committee, Nagpur  Approved 
Central India Medical Research Ethics Committtee, Nagpur  Approved 
Ethical Committe Niramaya Hospital Pvt. Ltd.  Approved 
Ethical Review Board M.S. Ramaiah Medical College  Approved 
Ethical Review Board Meenakshi Mission Hospital and Research Centre  Approved 
Ethics Committee Jehangir Clinical Development Centre  Approved 
Ethics Committee Lakeshore Hospital and Research Centre  Approved 
Ethics Committee Mediciti Hospitals  Approved 
Ethics Committee of Maharashtra Medical Research Society  Approved 
Ethics Committee of The Heart Care Clinic  Approved 
Ethics Committee Osmania Medical College  Approved 
Ethics Committee Poona Medical Research Foundation  Approved 
Ethics Committee PRS Hospital  Approved 
Ethics Committee Sir Ganga Ram Hospital  Approved 
Ethics Committee SUT Hospital  Approved 
Ethics Committee, LIMSAR, Ahmedabad  Approved 
Global Health Concern Ethics Committee  Approved 
Heart First Ethics Committee  Approved 
Human Research Ethics Committee  Approved 
Independent Ethics Committe Aditya  Approved 
Independent Ethics Committee Ludhiana  Approved 
Institutional Ethics Committee AMRI Hospitals  Approved 
Institutional Ethics Committee and Independent Review Board Jeevan Jyoti Hospital and Research Centre  Approved 
Institutional Ethics Committee Apollo Gleneagles Hospitals  Approved 
Institutional Ethics Committee Citi Cardiac Research Centre Ltd.  Approved 
Institutional Ethics Committee Deenanath Mangeshkar Hospital & Research Centre  Approved 
Institutional Ethics Committee for MV Hospital and Research Centre  Approved 
Institutional Ethics Committee Frontier Lifeline  Approved 
Institutional Ethics Committee Lisie Hospital  Approved 
Institutional Ethics Committee Maulana Azad Medical College  Approved 
Institutional Ethics Committee West Fort Hi-Tech Hospital  Approved 
Institutional Ethics Committee, KEMHRC, Pune  Approved 
Institutional Human Ethical Committee Kerala Institute of Medical Sciences  Approved 
Institutional Review Board MAGJ Hospital  Approved 
Institutional Review Board Fortis Hospital  Approved 
KMCH Ethics Committee  Approved 
Medanta Independent Ethics Committee  Approved 
National Health & Education Society Clinical Research & Ethics Committee  Approved 
PSG Institute of Medical Sciences & Research Institutional Ethics Committee  Approved 
Sanjivani Hospital Ethics Committee  Approved 
Scientific Advisory Research and Ethics Committee All India Heart Foundation  Approved 
SEAROC Ethics Committee  Approved 
Sri Jayadeva Institute Ethics Committee  Approved 
The Independent Ethics Committee  Approved 
Vijan Hospital Ethics Committee  Approved 
Vikram Hospital Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Approved/Obtained 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Acute Coronary Syndrome Myocardial Infarction Myocardial Ischemia Unstable Angina ,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  RIVAROXABAN  One 2.5 mg rivaroxaban tablet twice daily for up to 6 months or One 5 mg rivaroxaban tablet twice daily for up to 6 months  
Comparator Agent  Placebo  One placebo tablet twice daily for up to 6 months 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Inclusion Criteria:

Ages Eligible for Study: 18 Years and older. There is no upper age limit for this study.

Genders Eligible for Study: Both

Patients must be currently receiving aspirin therapy alone or in combination with a thienopyridine per national or local dosing recommendation
:Have been hospitalized for symptoms suggestive of acute coronary syndrome that lasted at least 10 minutes at rest and occurred 48 hours or less before going to the hospital
 
 
ExclusionCriteria 
Details  Exclusion Criteria:

Patient below 18 years of age.

Any condition that, in the opinion of the investigator, contraindicates anticoagulant therapy or would have an unacceptable risk of bleeding

Need for continued anticoagulant therapy

Significant renal impairment or known significant liver disease
 
 
Method of Generating Random Sequence    
Method of Concealment   Other 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Primary efficacy endpoint is the composite of CV death, MI, or stroke.   6-day screening phase, - treatment phase (consisting of double-blind treatment and follow-up) extending from Day 1 (baseline). - enrollment period estimated to last 27 months, the double-blind treatment phase will last for an additional 6 months, and the follow-up period will last 30 days, making the total study duration approximately 34 months. Study will end when at least 983 primary efficacy endpoints accrue across both strata, and at least 728 primary efficacy endpoints in Stratum 2 
 
Secondary Outcome  
Outcome  TimePoints 
The composite of all cause death, MI, or stroke. - Net clinical outcome, defined as the composite of CV death, MI, ischemic stroke, or TIMI major bleeding event not associated with CABG surgery - Assessments of the composite of CV death, MI, stroke, or severe recurrent ischemia requiring revascularization. - Assessments of the composite of CV death, MI, stroke, or severe recurrent ischemia leading to hospitalization.   6-day screening phase, - treatment phase (consisting of double-blind treatment and follow-up) extending from Day 1 (baseline). - enrollment period estimated to last 27 months, the double-blind treatment phase will last for an additional 6 months, and the follow-up period will last 30 days, making the total study duration approximately 34 months. Study will end when at least 983 primary efficacy endpoints accrue across both strata, and at least 728 primary efficacy endpoints in Stratum 2 - FPI: 28-Nov-2008, - LPI: 30-Jan-2011, - LPO: 27-Jun-2011 
 
Target Sample Size   Total Sample Size="15527"
Sample Size from India="2000" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/03/2009 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  26/11/2008 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details   Gibson CM, Mega JL, Burton P, Goto S, Verheugt F, Bode C, Plotnikov A, Sun X, Cook-Bruns N, Braunwald E. Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome. Am Heart J. 2011 May;161(5):815-821.e6. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  

The purpose of this study is to determine whether rivaroxaban in addition to standard care reduces the risk of the composite of cardiovascular death, myocardial infarction, or stroke in patients with a recent acute coronary syndrome compared with placebo.

 

Acute coronary syndrome (ACS) is a serious and life threatening condition. Following an acute coronary syndrome event patients are at risk of important additional clinical events such as death, myocardial infarction, and stroke. Six months after patients present with an index event of ST-segment myocardial infarction, approximately 15% will either have died or had another episode of myocardial ischemia, and a similar situation exists for non-ST-segment elevation myocardial infarction/unstable angina patients. This randomized; double-blind; placebo controlled study will evaluate the efficacy and safety of rivaroxaban in addition to standard care in patients with a recent ACS. Patients will be given rivaroxaban (2.5 mg twice daily or 5 mg twice daily) or placebo (twice daily) in addition to standard care.

 

India: 1550 patients screened, 1469 patients randomized, FPI: 10-Mar-2009, First subject randomized: 17-Mar-2009, Last Patient Enroled : 24-Dec-2010, Last Patient Last Visit : 09-Sep-2011

 
Close